Malignant Peripheral Nervous System Neoplasm

Malignant Peripheral Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

60 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20
Recruiting: 13
Ph III recruiting: 0
Growth YoY: —
Industry share: 20%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04222413	Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors	recruiting	Phase 1	116	National Cancer Institute (NCI)NIH	1	Sep 23, 2026	clinicaltrials
NCT05245500	Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion	recruiting	Phase 1	336	Bristol-Myers SquibbINDUSTRY	1	Sep 2, 2026	clinicaltrials
NCT05642455